JOHNSON & JOHNSON (Pharmaceutical Preparations)

Pharmaceutical Preparations

Filing Clarity monitors every SEC filing for JOHNSON & JOHNSON — Form 4 insider transactions, 8-K material events, and quarterly reports — and delivers plain-English signals with historical context.

Recent SEC filing signals

Filing Clarity delivers plain-English signals for each new filing, with historical context showing what changed from prior periods.

newsMicrosoft vs. Johnson & Johnson: Which Dividend Will Pay You More in 10 Years? (finance.yahoo.com)2026-09-30

newsWhy Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now (finance.yahoo.com)2026-09-30

newsABBV vs. JNJ: One of These Dividend Aristocrats Will Crush the Other Over the Next Decade (finance.yahoo.com)2026-09-25

newsJohnson & Johnson May Offload Its Orthopedics Unit for $20 Billion -- and Investors Shouldn't Miss What That Could Signal (finance.yahoo.com)2026-09-22

newsCHMP recommends approval of Johnson & Johnson’s TECVAYLI▼ (teclistamab) in relapsed/refractory multiple myeloma after at least one prior therapy (globenewswire.com)2026-09-18

newsCHMP recommends approval of Johnson & Johnson’s TECVAYLI▼ (teclistamab) in relapsed/refractory multiple myeloma after at least one prior therapy (finance.yahoo.com)2026-09-18